Nanoparticulate silver. A new antimicrobial substance for bone cement;Nanopartikuläres silber. Ein neues antimikrobielles agens für knochenzement

Orthopade

Volumn 33, Issue 8, 2004, Pages 885-892

  Alt, V ^a   Bechert, T ^b   Steinrucke P ^b   Wagener, M ^b   Seidel, P ^c   Dingeldein, E ^c   Scheddin, D ^d   Domann, E ^a   Schnettler, R ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Bio Gate GmbH   (Germany)

^c Coripharm GmbH and Co KG ^*  (Germany)

^d CYTOX   (Germany)

Author keywords

Infection; MRSA; MRSE; Nanoparticulate silver; PMMA

Indexed keywords

ANTIINFECTIVE AGENT; BONE CEMENT; GENTAMICIN; NANOPARTICLE; POLY(METHYL METHACRYLATE); SILVER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ELUTION; JOINT PROSTHESIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; MULTIDRUG RESISTANCE; NONHUMAN; PROSTHESIS INFECTION; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE CEMENTS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; FIBROBLASTS; GENTAMICINS; METHICILLIN RESISTANCE; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; NANOTECHNOLOGY; PARTICLE SIZE; POLYMETHYL METHACRYLATE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 4344581512     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Antti-Poika I, Josefsson G, Konttinen Y, Lidgren L, Santavirta S, Sanzen L (1990) Hip arthroplasty infection. Current concepts. Acta Orthop Scand 61: 163-169
2. Bechert T, Steinrücke P, Guggenbichler JP (2000) A new method for screening antibacterial biomaterials. Nature Med 6:1053-1056
3. Bechert T, Böswald M, Lugauer S, Regenfus A, Greil J, Guggenbichler JP (1999) The Erlanger Silver Catheter: In vitro results for antimicrobial activity. Infection Suppl 1: S24-S29
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
5. Bragg PD, Rainnie DJ (1973) The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 20: 883-889
6. Breusch SJ, Aldinger PR, Thomsen M, Ewerbeck V, Lukoschek M (2000) Anchoring principles in hip endoprostheses. I: Prosthesis stem. Unfallchirurg 103: 918-931
7. Buchholz HW, Engelbrecht H (1970) Über die Depotwirkung einiger Antibiotika bei Vermischung mit dem Kunstharz Palacos. Chirurg 40: 511-515
8. Butany J, Scully HE, VanArsdell G, Leask R (2002) Prosthetic heart valves with silver-coated cuff fabric: Early morphological features in two patients. Can J Cardiol 18: 733-738
9. Chu CS, McManus AT, Pruitt BA, Mason AD (1988) Therapeutic effects of silver nylon dressing with weak direct current on Pseudomans aeruginosa infected burn wounds. J Trauma 28: 1488-1492
10. Credé KSF. Die Verhütung der Augenentzündung der Neugeborenen, der häufigsten und wuchtigsten Ursache der Blindheit. A. Hirschwald, 1894
11. Davies J, Wright GD (1997) Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 5: 234-240
12. Deitch EA, Marin A, Malakanov V, Albright JA (1987) Silver nylon cloth: in vivo and in vitro evaluation of antimicrobial activity. J Trauma 27: 301-304
13. DiVincenzo GD, Giordano CJ, Schiever LS (1985) Biologic monitoring of workers exposed to silver. Int Arch Occup Environ Health 56: 205-215
14. Dueland R, Sparado JA, Rahn BA (1982) Silver antibacterial bone cement. Clin Orthop 169: 264-268
15. Espehaug B, Engesaeter LB,Vollset SE, Havelin LI, Langeland N (1997) Antibiotic prophylactics in total hip arthroplasty. J Bone Joint Surg Br 79: 590-595
16. Gupta A, Phung LT, Taylor DE, Silver S (2001) Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 147: 3393-3402
17. Hanssen AD (1999). Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 48: 111-122
18. Harris WH, Sledge CB (1990) The total hip and total knee replacement (Part II). N Engl J Med 323: 801-807
19. Holzegel K (1970) Über die Agyrose der Haut und Schleimhäute in der chemischen Industrie. Z Ges Hyg 16: 440-447
20. Josefsson G, Kolmert L (1993) Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1688 hips. Clin Orthop 292: 210-214
21. Karchmer TB, Giannetta ET, Muto CA, Strani BA, Farr BM (2000) A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 160: 3294-3298
22. Kilgus DJ, Howe DJ, Strang A (2002) Results of Periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop 404: 116-124
23. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, Kolter R (1999) Genetic approaches to study of biofilms. Methods Enzymol 310: 91-109
24. Peersman G, Laskin R, Davis J, Peterson M (2001) Infection in total knee arthroplasty. Clin Orthop 392: 1S-23
25. Petering HG (1976). Pharmacology and toxicology of heavy metals: silver. Pharmacol Ther A 1: 127-130
26. Rosenman KD, Moss A, Kon S (1979) Argyria: Clinical implications of exposure of silver nitrate and silver oxide. J Occup Med 21: 430-435
27. Schaff HV, Carrel TP, Jamieson WRE et al. (2002) Paravalvular leak and other events in Silzone-coated mechanical heart valves: A report from AVERT. Ann Thorac Surg 73: 785-792
28. Schreurs WJ, Rosenberg H (1982) Effect of silver ions on transport and retention of phosphate by Escherichia coli. J Bacteriol 152: 7-13
29. Sudmann E, Vik H, Rait M et al. (1994) Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med Progress Technol 20: 179-184
30. Thierse L (1978). Erfahrungen mit Refobacin-Palacos im Hinblick auf die tiefen Spätinfektionen nach Hüftoperationen. Z Orthop 116: 847-849
31. Thornes B, Murray P, Bouchier-Hayes D (2002) Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 84: 758-760
32. Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ (1997) Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves. J Heart Valve Dis 6: 553-561
33. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ (2001) Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 72: 557-571
34. Vik H, Andersen KJ, Julshamn K, Todnem (1985) Neuropathy caused by silver absorption from arthroplasty cement. Lancet 13: 872
35. von Eiff C, Lindner N, Proctor RA, Winkelmann W, Peters G (1998) Development of gentamicin-resistant small colony variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence. Z Orthop 136: 268-271
36. Wahlig H, Dingeldein E, Buchholz HW, Buchholz M, Bachmann F (1984) Pharmacokinetic study of gentamicin based cement in total hip replacements. J Bone Joint Surg Br 66: 175-179
37. Wahlig H (1987) Über die Freisetzungskinetik von Antibiotika aus Knochenzementen - Ergebnisse vergleichender Untersuchungen in vitro und in vivo. In: Willert H-G, Buchhorn G (Hrsg) Technical principles, design and safety of joint implants. Hogrefe & Huber, Göttingen, S 221-226
38. Wannske M, Tscherne H (1979) Ergebnisse prophylaktischer Anwendung von Refobacin-Palacos bei der Implantation von Endoprothesen des Hüftgelenkes in Hannover. In: Burri C, Rüter A (Hrsg) Lokalbehandlung chirurgischer Infektionen. Akt Probl Chir Ortho 12: 201-208